These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

604 related articles for article (PubMed ID: 8727374)

  • 1. [Studies on nuclear DNA content in bladder cancers using flow cytometry].
    Toyota K
    Hokkaido Igaku Zasshi; 1996 Jan; 71(1):45-53. PubMed ID: 8727374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Flow cytometric analysis of the DNA content of the urinary bladder cancers--study on the DNA heterogeneity in bladder cancers].
    Toyota K; Nagamori S; Kashiwagi A; Nonomura K; Koyanagi T
    Nihon Hinyokika Gakkai Zasshi; 1995 Aug; 86(8):1353-9. PubMed ID: 7474619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of flow cytometric deoxyribonucleic acid measurements of deparaffinized specimens in bladder tumors.
    Miao T; Wang Z; Sang N; Xiong R; Cao S
    Eur Urol; 1992; 21(2):98-102. PubMed ID: 1499623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The clinical significance of flow cytometric DNA measurement of paraffin specimen in bladder tumor].
    Wang Z
    Zhonghua Wai Ke Za Zhi; 1990 Aug; 28(8):505-8, 512. PubMed ID: 2086120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA flow cytometric analysis of clinical stage I endometrial carcinomas with lymph node metastases.
    Coleman RL; Schink JC; Miller DS; Bauer KD; August CZ; Rademaker AW; Lurain JR
    Gynecol Oncol; 1993 Jul; 50(1):20-4. PubMed ID: 8349159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytofluorimetric evaluation of DNA ploidy in the diagnosis of bladder cancer.
    Armone S; Voce S; dal Pozzo C; Severini G; Montanari F; Monti G; Tavolazzi L
    Arch Esp Urol; 1998 Jun; 51(5):507-10. PubMed ID: 9675952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors for survival in patients with transitional cell carcinoma of the bladder: evaluation by histopathologic grade, pathologic stage and flow-cytometric analysis.
    Lee SE; Park MS
    Eur Urol; 1996; 29(2):193-8. PubMed ID: 8647146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of static cytometry in transitional cell carcinoma of the bladder: recurrence rate and survival in a group of patients at 10 years follow-up.
    Cai T; Margallo E; Nesi G; Giubilei G; Rizzo M; Bartoletti R
    Oncol Rep; 2006 Jan; 15(1):213-9. PubMed ID: 16328058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The DNA content of bladder carcinoma in relation to pathologic grading, staging and prognosis: a flow cytometric study].
    Xue J
    Zhonghua Wai Ke Za Zhi; 1989 Nov; 27(11):650-3, 700. PubMed ID: 2632194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA ploidy as a prognostic factor in muscle invasive transitional cell carcinoma of the bladder.
    Deliveliotis C; Georgoulakis J; Skolarikos A; Trakas N; Varkarakis J; Albanis S; Protogerou B; Bamias A
    Urol Res; 2005 Feb; 33(1):39-43. PubMed ID: 15258707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relations of proliferative activities of gastric carcinoma cells to lymphatic involvement, venous invasion and prognosis.
    Wu YF; Xu HM; Chen JQ
    Chin Med J (Engl); 2004 Oct; 117(10):1530-5. PubMed ID: 15498378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Studies on nuclear DNA content in testicular germ cell tumors using flow cytometry].
    Kashiwagi A
    Hokkaido Igaku Zasshi; 1992 Nov; 67(6):801-14. PubMed ID: 1336479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prognostic significance of DNA content in transitional cell carcinoma of the urinary bladder].
    Sun X
    Zhonghua Zhong Liu Za Zhi; 1992 Jan; 14(1):24-6. PubMed ID: 1396041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Flow cytometric analysis of DNA content of urinary bladder cancers--study on primary tumors and metastasized lymph nodes].
    Toyota K; Nagamori S; Kashiwagi A; Nonomura K; Koyanagi T
    Nihon Hinyokika Gakkai Zasshi; 1995 Sep; 86(9):1435-9. PubMed ID: 7474632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical cancer progression in urinary bladder tumors evaluated by multiparameter flow cytometry with monoclonal antibodies. Laval University Urology Group.
    Fradet Y; Tardif M; Bourget L; Robert J
    Cancer Res; 1990 Jan; 50(2):432-7. PubMed ID: 2295082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deoxyribonucleic acid ploidy and the clinical pattern of grade 2 superficial bladder cancer.
    Neulander E; Kaneti J; Chaimovitz C; Sion-Vardy N; Douvdevani A
    J Urol; 1997 Apr; 157(4):1254-8; discussion 1258-9. PubMed ID: 9120914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Flow cytometric analysis of DNA ploidy using paraffin-embedded germ cell tumors].
    Yoshihiro S; Yamamoto M; Shimabukuro T; Matsuyama H; Yamamoto N; Sakatoku J
    Hinyokika Kiyo; 1991 Jun; 37(6):601-5. PubMed ID: 1892008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of numerical chromosome aberrations using in situ hybridization in paraffin sections of routinely processed bladder cancers.
    Hopman AH; van Hooren E; van de Kaa CA; Vooijs PG; Ramaekers FC
    Mod Pathol; 1991 Jul; 4(4):503-13. PubMed ID: 1924281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of DNA ploidy in breast cancer stage I-II.
    Cufer T; Lamovec J; Bracko M; Lindtner J; Us-Krasovec M
    Neoplasma; 1997; 44(2):127-32. PubMed ID: 9201293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA content and proliferation activity in superficial transitional cell carcinoma of the bladder.
    Pantazopoulos D; Ioakim-Liossi A; Karakitsos P; Aroni K; Kakoliris S; Kanavaros P; Kyrkou KA
    Anticancer Res; 1997; 17(1B):781-6. PubMed ID: 9066620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.